Yahoo Web Search

Search results

    • Q1 2024 OncoCyte Corp Earnings Call

      Thomson Reuters StreetEvents via Yahoo Finance· 13 minutes ago

      Our value proposition in transplant monitoring is simple. We offer an easy-to-use test, a rapid turnaround time, and attractive economics for ourselves, customers...improve ...

    • Is It Too Late to Buy Palantir Stock?

      Is It Too Late to Buy Palantir Stock?

      Motley Fool via Yahoo Finance· 8 hours ago

      Additionally, the full-year 2024 revenue forecast calls for just under $2.7 billion. That would mean a 20% annual revenue-growth rate, which may not be...